Effects of 20 mg oral Δ(9) -tetrahydrocannabinol on the olfactory function of healthy volunteers.
British Journal of Clinical Pharmacology November 2014 Carmen Walter, Bruno G Oertel, Dagmar Ludyga et al.
Olfactory loss impairs the patient's quality of life. In individualized therapies, olfactory drug effects gain clinical importance. Molecular evidence suggests that among drugs with potential olfactory effects is Δ(9) -tetrahydrocannabinol (THC), which is approved for several indications, including neuropathic pain or analgesia in cancer patients. The present study aimed at assessing the...
DOI: 10.1111/bcp.12415 (opens in new tab)
Full text (opens in new tab)
Cannabinoids
Olfaction
Sensory pharmacology
Δ9-tetrahydrocannabinol